BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 32600270)

  • 1. Nosocomial infections due to multidrug-resistant bacteria in cancer patients: a six-year retrospective study of an oncology Center in Western China.
    Jiang AM; Shi X; Liu N; Gao H; Ren MD; Zheng XQ; Fu X; Liang X; Ruan ZP; Yao Y; Tian T
    BMC Infect Dis; 2020 Jun; 20(1):452. PubMed ID: 32600270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical and epidemiological risk factors of infections due to multi-drug resistant bacteria in an adult intensive care unit of University Hospital Center in Marrakesh-Morocco.
    El Mekes A; Zahlane K; Ait Said L; Tadlaoui Ouafi A; Barakate M
    J Infect Public Health; 2020 Apr; 13(4):637-643. PubMed ID: 31537511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009.
    Zilberberg MD; Shorr AF
    J Hosp Med; 2013 Oct; 8(10):559-63. PubMed ID: 24022878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nosocomial infections in the medical ICU: a retrospective study highlighting their prevalence, microbiological profile and impact on ICU stay and mortality.
    Pradhan NP; Bhat SM; Ghadage DP
    J Assoc Physicians India; 2014 Oct; 62(10):18-21. PubMed ID: 25906516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013-2017.
    Gupta V; Ye G; Olesky M; Lawrence K; Murray J; Yu K
    BMC Infect Dis; 2019 Aug; 19(1):742. PubMed ID: 31443635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First prevalence of metallo beta-lactamases producing Enterobacteriacea in Iranian cancer patients.
    Zare D; Fazeli H
    Ann Ig; 2019; 31(1):62-68. PubMed ID: 30554240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
    Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
    Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia.
    Kader AA; Kumar AK
    Saudi Med J; 2004 May; 25(5):570-4. PubMed ID: 15138522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
    Zhang H; Yang Q; Liao K; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Hu Z; Chu Y; Chen S; Cao B; Su J; Gui B; Duan Q; Zhang S; Shao H; Kong H; Badal RE; Xu Y
    Antimicrob Agents Chemother; 2016 Jan; 60(1):245-51. PubMed ID: 26482308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
    Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F
    Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteremic Urinary Tract Infection Caused by Multidrug-Resistant Enterobacteriaceae Are Associated With Severe Sepsis at Admission: Implication for Empirical Therapy.
    Lee YC; Hsiao CY; Hung MC; Hung SC; Wang HP; Huang YJ; Wang JT
    Medicine (Baltimore); 2016 May; 95(20):e3694. PubMed ID: 27196480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Antibiotic Resistance in Urinary Tract Infection Patients with Prior Urine Cultures.
    Dickstein Y; Geffen Y; Andreassen S; Leibovici L; Paul M
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4717-21. PubMed ID: 27216064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended-spectrum β-lactamase-producing Enterobacteriaceae, national study of antimicrobial treatment for pediatric urinary tract infection.
    Lagree M; Bontemps S; Dessein R; Angoulvant F; Madhi F; Martinot A; Cohen R; Dubos F;
    Med Mal Infect; 2018 May; 48(3):193-201. PubMed ID: 29449049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study.
    Motbainor H; Bereded F; Mulu W
    BMC Infect Dis; 2020 Jan; 20(1):92. PubMed ID: 32000693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug-resistant infections in long-term care facilities: extended-spectrum β-lactamase-producing Enterobacteriaceae and hypervirulent antibiotic resistant Clostridium difficile.
    Giufrè M; Accogli M; Ricchizzi E; Barbanti F; Farina C; Fazii P; Mattei R; Sarti M; Barozzi A; Buttazzi R; Cosentino M; Nardone M; Savini V; Spigaglia P; Moro ML; Cerquetti M
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):275-281. PubMed ID: 29571838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of infection caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: development of a clinical decision-making nomogram.
    García-Tello A; Gimbernat H; Redondo C; Meilán E; Arana DM; Cacho J; Dorado JF; Angulo JC
    Scand J Urol; 2018 Feb; 52(1):70-75. PubMed ID: 28893132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance and impact on mortality of extended-spectrum beta lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia.
    Menashe G; Borer A; Yagupsky P; Peled N; Gilad J; Fraser D; Riesenberg K; Schlaeffer F
    Scand J Infect Dis; 2001; 33(3):188-93. PubMed ID: 11303808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral treatment options for patients with urinary tract infections caused by extended spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae.
    Raja NS
    J Infect Public Health; 2019; 12(6):843-846. PubMed ID: 31176606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of multidrug-resistant bacteria in patients with long hospital stays.
    Buke C; Armand-Lefevre L; Lolom I; Guerinot W; Deblangy C; Ruimy R; Andremont A; Lucet JC
    Infect Control Hosp Epidemiol; 2007 Nov; 28(11):1255-60. PubMed ID: 17926276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.